Barbara Ruskin - Net Worth and Insider Trading

Barbara Ruskin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Barbara Ruskin owns 1 companies in total, including Virpax Pharmaceuticals Inc (VRPX) .

Click here to see the complete history of Barbara Ruskin’s form 4 insider trades.

Insider Ownership Summary of Barbara Ruskin

Ticker Comapny Transaction Date Type of Owner
VRPX Virpax Pharmaceuticals Inc 2023-03-24 director

Barbara Ruskin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Barbara Ruskin Ownership Network

Ownership Network List of Barbara Ruskin

No Data

Ownership Network Relation of Barbara Ruskin

Insider Network Chart

Barbara Ruskin Owned Company Details

What does Virpax Pharmaceuticals Inc do?

Who are the key executives at Virpax Pharmaceuticals Inc?

Barbara Ruskin is the director of Virpax Pharmaceuticals Inc. Other key executives at Virpax Pharmaceuticals Inc include Chief Scientific Officer Sheila Mathias , Chief Financial Officer Vinay Shah , and director & 10 percent owner & Chief Executive Officer Anthony P. Mack .

Virpax Pharmaceuticals Inc (VRPX) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Virpax Pharmaceuticals Inc (VRPX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Virpax Pharmaceuticals Inc (VRPX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Virpax Pharmaceuticals Inc (VRPX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Virpax Pharmaceuticals Inc Insider Transactions

No Available Data

Barbara Ruskin Mailing Address

Above is the net worth, insider trading, and ownership report for Barbara Ruskin. You might contact Barbara Ruskin via mailing address: C/o Virpax Pharmaceuticals, Inc., 1055 Westlakes Drive, Suite 300, Berwyn Pa 19312.

Discussions on Barbara Ruskin

No discussions yet.